Optimization of the treatment of chronic inflammatory diseases of the genital organs in women of fertile age, taking into account international experience

Authors: Candidate of Medical Sciences, Senior Researcher Podolsky Vl. V. – Head of the Department of Health Problems of Women of Childbearing Age State Institution “Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine”, Kyiv

Podolsky V.V., MD, PhD, Head of the Department of Health Problems of Women of Childbearing Age State Institution “Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine”, Kyiv, tel. 044-484-40-64

PhD in Medicine, Professor Fedorich P.V. – Professor of the Department of Military General Practice – Family Medicine of the Ukrainian Military Medical Academy. Head of the course of dermatology and venereology, Kyiv

State Institution “Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine”


Studies of leading scientists of our country [4,5] conducted in previous years have shown that the state of reproductive health of the population of Ukraine is of particular concern, as it not only does not meet international standards, but especially in the last decade has been affected by various negative factors that continue to cause an increase in female morbidity.

A particular threat to women’s reproductive health is posed by chronic inflammatory diseases of the genital organs, which, if not diagnosed and treated in a timely manner, affect the risk of other reproductive health disorders, such as infertility, menstrual irregularities, hyperplastic changes in the genital organs and other complications that occur in combination with changes in autonomic homeostasis [3,6].

Difficult conditions of modern life, which are expressed not only in changes in socio-economic conditions, deterioration of the environmental situation and the spread of infections, including those transmitted by sexually transmitted diseases, lead to a decrease in the number of women who have uncomplicated pregnancy and childbirth. The state of women’s health, which is affected by somatic morbidity, in particular somatoform diseases accompanied by disorders of autonomic homeostasis and gynecological morbidity, causes the development of obstetric and perinatal complications, which leads to the birth of children in a disturbed state.

The importance of the problem lies in the fact that in recent years, the proportion of inflammatory diseases of the female genital organs, among other gynecological pathologies, has been increasing. Infection of the population, especially of young reproductive age, is a threat not only to the health of the population of our country, but also an unfavorable factor that can affect the health of future generations.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design